CXCL12 and breast carcinoma: So far, data regarding the involvement of the CXCR4/CXCL12 axis in FMC revealed that CXCR4 is overexpressed in the majority of FMC [21–23] with frequent metastization at lymph node, liver and lung as reported in human breast cancer.